Pat Mitchell
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
Papers in
- Co-authors
- Paul Martin (4 shared papers)Dennis W. Schneck (4 shared papers)Kathleen Butler (6 shared papers)Renli Teng (4 shared papers)Rongyue Teng (2 shared papers)Steven G. Simonson (2 shared papers)Kenneth C. Lasseter (1 shared paper)Bruce K. Birmingham (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (3 papers)Cancer Research (3 papers)Annals of Oncology (2 papers)The Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Pat Mitchell
22 papers receiving 548 citations
Peers
Comparison fields: 5 of 67
- Internal Medicine 51
- Cardiology and Cardiovascular Medicine 149
- Pharmacology 53
- Oncology 146
- Surgery 195
Countries citing papers authored by Pat Mitchell
This map shows the geographic impact of Pat Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pat Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pat Mitchell more than expected).
Fields of papers citing papers by Pat Mitchell
This network shows the impact of papers produced by Pat Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pat Mitchell. The network helps show where Pat Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside Pat Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 126 | |
| 2 | 2015 | 61 | |
| 3 | 2012 | 53 | |
| 4 | 2005 | 40 | |
| 5 | 2008 | 35 | |
| 6 | 2014 | 33 | |
| 7 | 2018 | 30 | |
| 8 | 2012 | 29 | |
| 9 | 2012 | 26 | |
| 10 | 2004 | 23 | |
| 11 | 2019 | 20 | |
| 12 | 2018 | 19 | |
| 13 | 2011 | 17 | |
| 14 | 2023 | 14 | |
| 15 | 2017 | 9 | |
| 16 | 2016 | 7 | |
| 17 | 2013 | 6 | |
| 18 | 2015 | 5 | |
| 19 | 2019 | 4 | |
| 20 | 2018 | 1 |
About Pat Mitchell
Pat Mitchell is a scholar working on Oncology, Surgery, Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 560 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Pharmacogenetics and Drug Metabolism (3 papers), Adenosine and Purinergic Signaling (3 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Internal Medicine (51 citations), Cardiology and Cardiovascular Medicine (149 citations), Pharmacology (53 citations), Oncology (146 citations) and Surgery (195 citations). Pat Mitchell has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Paul Martin, Dennis W. Schneck, Kathleen Butler, Renli Teng, Rongyue Teng, Steven G. Simonson, Kenneth C. Lasseter, Bruce K. Birmingham, Ann S. LaCasce and Andrei R. Shustov. Their work appears in journals such as European Journal of Clinical Pharmacology, Cancer Research, Annals of Oncology, The Journal of Clinical Pharmacology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.